Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced the initiation of Part B of ...
In the Nanovision project, researchers at Empa and the Cantonal Hospital of St. Gallen are developing novel nanocomplexes that kill resistant germs and protect the eye tissue at the same time. In ...